Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › budesonide

budesonide

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of budesonide

35 trials tracked of budesonide: 20 in phase 3 or 4 and 6 with published results. The most-cited published study has 105 citations.

35Trials tracked
20Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 4 6 Phase 3 14 Phase 2 10 Phase 1 1 Other / NA 4
  1. Phase 3 Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Completed · 105 cited
  2. Phase 3 Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Completed · 105 cited
  3. Phase 4 The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis Completed · 73 cited
  4. Phase 3 Altitude Sickness Prevention and Efficacy of Comparative Treatments Completed · 36 cited
  5. Phase 4 Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD Completed · 19 cited
  6. Phase 3 A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma Completed · 18 cited
Show 29 more trials
  1. Phase 4 Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD Completed
  2. Phase 4 Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis) Completed
  3. Phase 4 Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans Completed
  4. Phase 4 NasoNeb Delivery of an Intranasal Steroid Completed
  5. Phase 3 Dupilumab in Chinese Adult Participants With CRSwNP Completed
  6. Phase 3 The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis Completed
  7. Phase 3 Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. Completed
  8. Phase 3 Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed
  9. Phase 3 Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma Completed
  10. Phase 3 CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST) Completed
  11. Phase 3 Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients Completed
  12. Phase 3 (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets Completed
  13. Phase 3 The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room Completed
  14. Phase 3 New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day Completed
  15. Phase 2 Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Completed
  16. Phase 2 Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients Completed
  17. Phase 2 LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Completed
  18. Phase 2 Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi Completed
  19. Phase 2 Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis Completed
  20. Phase 2 An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide Completed
  21. Phase 2 Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis Completed
  22. Phase 2 Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer Completed
  23. Phase 2 Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy Completed
  24. Phase 2 A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo Completed
  25. Phase 1 A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults Completed
  26. N/A The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery Completed
  27. N/A Role of microRNAs in T Cell-Driven Inflammation in Asthma Completed
  28. N/A Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population Completed
  29. N/A Acupuncture Therapy for COVID-Related Olfactory Loss Completed

Showing the 35 most-cited and recently-updated of 35 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance
Pulmonology & Critical Care FDA Approval
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance FDA approves new triple-combination inhaler Breztri Aerosphere for COPD.
The FDA approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for maintenance treatment of COPD. It is a triple-combin…
The FDA approved Breztri Aerosphere, a triple-combination inhaler, for the long-term treatment of chronic obstructive pulmonary disease (COP…
FDA May 2, 2026
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
Allergy & Immunology RCT
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma New Asthma Drug Cuts Attacks Without Recent Crisis
This phase 3 randomised, double-blind, double-dummy, parallel-group trial evaluated budesonide-glycopyrronium-formoterol fumarate dihydrate …
A new asthma combo therapy improves breathing and lowers severe flare-up risk for patients who haven't had a recent emergency room visit.
Apr 14, 2026